Patient preference for either the EORTC QLQ-C30 or the FACIT Quality of Life (QOL) measures: A study performed in patients suffering from carcinoma of an unknown primary site (CUP)

C. Rodary; V. Pezet-Langevin; S. Garcia-Acosta; T. Lesimple; A. Lortholary; M. C. Kaminsky; J. Bennouna; S. Culine; H. Bourgeois; Karim Fizazi

doi:10.1016/j.ejca.2003.11.002

Patient preference for either the EORTC QLQ-C30 or the FACIT Quality of Life (QOL) measures: A study performed in patients suffering from carcinoma of an unknown primary site (CUP)

C. Rodary, V. Pezet-Langevin, S. Garcia-Acosta, T. Lesimple, A. Lortholary, M. C. Kaminsky, J. Bennouna, S. Culine, H. Bourgeois, Karim Fizazi

Research output: Contribution to journal › Article › peer-review

21 Citations (Scopus)

Abstract

The objective of this study was to examine and compare two core measures of Quality Of Life (QOL) used in cancer clinical trials: the European Organisation for Research and Treatment of Cancer QOL Core Questionnaire 30 (EORTC QLQ-30) and the Functional Assessment of Chronic Illness Therapy (FACIT), in order to identify which one patients have the strongest preference for using. 68 patients suffering from Carcinomas of an Unknown Primary site (CUP) were recruited in a multicentric study; all of them completed both questionnaires, administered in a randomised manner. The criteria were the percentage of preferences, and four indicators of acceptability. The results indicated that an equal proportion of patients preferred the QLQ-C30 (19%) and FACIT (19%). 54% of patients felt both questionnaires were acceptable. All the indicators of acceptability favoured the QLQ-C30. Analysis of open-ended questions shed light on the difficulties encountered by the patients. As no significant preference was observed for one of the questionnaires, the QLQ-C30 was chosen on the basis of its significantly better acceptability criteria.

Original language	English
Pages (from-to)	521-528
Number of pages	8
Journal	European Journal of Cancer
Volume	40
Issue number	4
DOIs	https://doi.org/10.1016/j.ejca.2003.11.002
Publication status	Published - 1 Jan 2004

Keywords

Carcinoma of an Unknown Primary site
FACIT
Preference
QLQ-C30
Quality Of Life

Access to Document

10.1016/j.ejca.2003.11.002

Cite this

Rodary, C., Pezet-Langevin, V., Garcia-Acosta, S., Lesimple, T., Lortholary, A., Kaminsky, M. C., Bennouna, J., Culine, S., Bourgeois, H., & Fizazi, K. (2004). Patient preference for either the EORTC QLQ-C30 or the FACIT Quality of Life (QOL) measures: A study performed in patients suffering from carcinoma of an unknown primary site (CUP). European Journal of Cancer, 40(4), 521-528. https://doi.org/10.1016/j.ejca.2003.11.002

@article{34a0f6b794b548a4aea02ba66db59088,

title = "Patient preference for either the EORTC QLQ-C30 or the FACIT Quality of Life (QOL) measures: A study performed in patients suffering from carcinoma of an unknown primary site (CUP)",

abstract = "The objective of this study was to examine and compare two core measures of Quality Of Life (QOL) used in cancer clinical trials: the European Organisation for Research and Treatment of Cancer QOL Core Questionnaire 30 (EORTC QLQ-30) and the Functional Assessment of Chronic Illness Therapy (FACIT), in order to identify which one patients have the strongest preference for using. 68 patients suffering from Carcinomas of an Unknown Primary site (CUP) were recruited in a multicentric study; all of them completed both questionnaires, administered in a randomised manner. The criteria were the percentage of preferences, and four indicators of acceptability. The results indicated that an equal proportion of patients preferred the QLQ-C30 (19%) and FACIT (19%). 54% of patients felt both questionnaires were acceptable. All the indicators of acceptability favoured the QLQ-C30. Analysis of open-ended questions shed light on the difficulties encountered by the patients. As no significant preference was observed for one of the questionnaires, the QLQ-C30 was chosen on the basis of its significantly better acceptability criteria.",

keywords = "Carcinoma of an Unknown Primary site, FACIT, Preference, QLQ-C30, Quality Of Life",

author = "C. Rodary and V. Pezet-Langevin and S. Garcia-Acosta and T. Lesimple and A. Lortholary and Kaminsky, {M. C.} and J. Bennouna and S. Culine and H. Bourgeois and Karim Fizazi",

year = "2004",

month = jan,

day = "1",

doi = "10.1016/j.ejca.2003.11.002",

language = "English",

volume = "40",

pages = "521--528",

journal = "European Journal of Cancer",

issn = "0959-8049",

number = "4",

}

Rodary, C, Pezet-Langevin, V, Garcia-Acosta, S, Lesimple, T, Lortholary, A, Kaminsky, MC, Bennouna, J, Culine, S, Bourgeois, H & Fizazi, K 2004, 'Patient preference for either the EORTC QLQ-C30 or the FACIT Quality of Life (QOL) measures: A study performed in patients suffering from carcinoma of an unknown primary site (CUP)', European Journal of Cancer, vol. 40, no. 4, pp. 521-528. https://doi.org/10.1016/j.ejca.2003.11.002

Patient preference for either the EORTC QLQ-C30 or the FACIT Quality of Life (QOL) measures: A study performed in patients suffering from carcinoma of an unknown primary site (CUP). / Rodary, C.; Pezet-Langevin, V.; Garcia-Acosta, S. et al.
In: European Journal of Cancer, Vol. 40, No. 4, 01.01.2004, p. 521-528.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Patient preference for either the EORTC QLQ-C30 or the FACIT Quality of Life (QOL) measures

T2 - A study performed in patients suffering from carcinoma of an unknown primary site (CUP)

AU - Rodary, C.

AU - Pezet-Langevin, V.

AU - Garcia-Acosta, S.

AU - Lesimple, T.

AU - Lortholary, A.

AU - Kaminsky, M. C.

AU - Bennouna, J.

AU - Culine, S.

AU - Bourgeois, H.

AU - Fizazi, Karim

PY - 2004/1/1

Y1 - 2004/1/1

N2 - The objective of this study was to examine and compare two core measures of Quality Of Life (QOL) used in cancer clinical trials: the European Organisation for Research and Treatment of Cancer QOL Core Questionnaire 30 (EORTC QLQ-30) and the Functional Assessment of Chronic Illness Therapy (FACIT), in order to identify which one patients have the strongest preference for using. 68 patients suffering from Carcinomas of an Unknown Primary site (CUP) were recruited in a multicentric study; all of them completed both questionnaires, administered in a randomised manner. The criteria were the percentage of preferences, and four indicators of acceptability. The results indicated that an equal proportion of patients preferred the QLQ-C30 (19%) and FACIT (19%). 54% of patients felt both questionnaires were acceptable. All the indicators of acceptability favoured the QLQ-C30. Analysis of open-ended questions shed light on the difficulties encountered by the patients. As no significant preference was observed for one of the questionnaires, the QLQ-C30 was chosen on the basis of its significantly better acceptability criteria.

AB - The objective of this study was to examine and compare two core measures of Quality Of Life (QOL) used in cancer clinical trials: the European Organisation for Research and Treatment of Cancer QOL Core Questionnaire 30 (EORTC QLQ-30) and the Functional Assessment of Chronic Illness Therapy (FACIT), in order to identify which one patients have the strongest preference for using. 68 patients suffering from Carcinomas of an Unknown Primary site (CUP) were recruited in a multicentric study; all of them completed both questionnaires, administered in a randomised manner. The criteria were the percentage of preferences, and four indicators of acceptability. The results indicated that an equal proportion of patients preferred the QLQ-C30 (19%) and FACIT (19%). 54% of patients felt both questionnaires were acceptable. All the indicators of acceptability favoured the QLQ-C30. Analysis of open-ended questions shed light on the difficulties encountered by the patients. As no significant preference was observed for one of the questionnaires, the QLQ-C30 was chosen on the basis of its significantly better acceptability criteria.

KW - Carcinoma of an Unknown Primary site

KW - FACIT

KW - Preference

KW - QLQ-C30

KW - Quality Of Life

UR - http://www.scopus.com/inward/record.url?scp=10744231245&partnerID=8YFLogxK

U2 - 10.1016/j.ejca.2003.11.002

DO - 10.1016/j.ejca.2003.11.002

M3 - Article

C2 - 14962718

AN - SCOPUS:10744231245

SN - 0959-8049

VL - 40

SP - 521

EP - 528

JO - European Journal of Cancer

JF - European Journal of Cancer

IS - 4

ER -

Patient preference for either the EORTC QLQ-C30 or the FACIT Quality of Life (QOL) measures: A study performed in patients suffering from carcinoma of an unknown primary site (CUP)

Abstract

Keywords

Access to Document

Other files and links

Cite this